SEC Form 4 · accession 0001209191-15-003427
TETRAPHASE PHARMACEUTICALS INC · TTPH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Guy Macdonald
Officer — President and Chief Executive · Director
Period of report
Jan 7, 2015
Accepted (ET)
Jan 9, 2015 · 4:47 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001373707
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy)F1 | $39.94 | Jan 7, 2015 | A | 200,000 | A | — | Jan 6, 2025 | Common Stock | 200,000 | 200,000 | D |
Explanation of responses
- F1Vests as to 6.25% of the shares on 4/7/2015 and further vests as to an additional 6.25% of the original grant at the end of each successive three-month period thereafter until 1/7/2019.